...
首页> 外文期刊>Analytical methods >A capillary zone electrophoretic method for the determination of hypoglycemics as adulterants in herbal formulations used for the treatment of diabetes
【24h】

A capillary zone electrophoretic method for the determination of hypoglycemics as adulterants in herbal formulations used for the treatment of diabetes

机译:毛细管区带电泳法测定用于治疗糖尿病的草药制剂中作为掺假剂的降血糖药

获取原文
           

摘要

Adulteration of antidiabetic herbal medicines with hypoglycemic drugs has been reported as a recurrent practice throughout the world. In this context, a new method for the determination of metformin, chlorpropamide, glibenclamide and gliclazide by capillary zone electrophoresis (CZE) with capacitively coupled contactless conductivity detection (C4D) is described in this paper. The proposed method was applied to the evaluation of adulterants in samples of herbal formulations commercialized by compounding pharmacies for the treatment of diabetes mellitus. The method was shown to be suitable for the simultaneous evaluation of hypoglycemics as adulterants using a 20 mmol La?’1 sodium acetate solution at pH 10.0 as the working electrolyte. The method allows for the quantification of the adulterants in concentrations higher than 0.24 mg per capsule for metformin, 0.42 mg per capsule for chlorpropamide, 0.15 mg per capsule for glibenclamide and 0.33 mg per capsule for gliclazide.
机译:据报道,降糖药与降糖药一起掺假是世界范围内的普遍做法。在此背景下,本文介绍了一种通过毛细管区带电泳(CZE)和电容耦合非接触电导检测(C4D)测定二甲双胍,氯丙酰胺,格列本脲和格列齐特的新方法。该方法用于复方药房商品化的中草药制剂样品中掺假药的评估,以治疗糖尿病。结果表明,该方法适用于同时使用pH为10.0的20 mmol La?’1乙酸钠溶液作为工作电解质,同时作为掺假剂来评估降血糖药。该方法可以对掺假品进行定量,其浓度分别为:二甲双胍每胶囊0.24 mg,氯丙酰胺每胶囊0.42 mg,格列苯脲每胶囊0.15 mg和格列齐特每胶囊0.33 mg。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号